Genentech delves into apps to link with breast cancer patients
Over years of cancer drug research, Genentech Inc. has kept a keen watch on patients: how they respond to drugs in a clinical trial, for example, or what patients need in a next-generation drug.
Yet even as the South San Francisco-based biotech unit of Swiss drug giant Roche developed some of the best-selling and effective cancer drugs — Avastin and Herceptin among them — it heard from patients that the medications themselves were not enough.
Breast cancer patients, in particular, wanted to…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
More News: Avastin | Biotechnology | Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | Health | Health Management | Herceptin | Pharmaceuticals